Luteolin and its inhibitory effect on tumor growth in systemic malignancies.

[1]  Mi-Kyung Sung,et al.  Luteolin exerts anti-tumor activity through the suppression of epidermal growth factor receptor-mediated pathway in MDA-MB-231 ER-negative breast cancer cells. , 2012, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[2]  R. Béliveau,et al.  Diet-derived polyphenols inhibit angiogenesis by modulating the interleukin-6/STAT3 pathway. , 2012, Experimental cell research.

[3]  W. Zou,et al.  Luteolin inhibits proliferation induced by IGF-1 pathway dependent ERα in human breast cancer MCF-7 cells. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[4]  Jae Hyun Kim,et al.  Luteolin induces apoptotic cell death through AIF nuclear translocation mediated by activation of ERK and p38 in human breast cancer cell lines , 2012, Cell biology international.

[5]  Hong Tang,et al.  A Superoxide-Mediated Mitogen-Activated Protein Kinase Phosphatase-1 Degradation and c-Jun NH2-Terminal Kinase Activation Pathway for Luteolin-Induced Lung Cancer Cytotoxicity , 2012, Molecular Pharmacology.

[6]  H. Cho,et al.  Luteolin decreases IGF-II production and downregulates insulin-like growth factor-I receptor signaling in HT-29 human colon cancer cells , 2012, BMC Gastroenterology.

[7]  Hong Sun,et al.  Luteolin enhances TNF-related apoptosis-inducing ligand's anticancer activity in a lung cancer xenograft mouse model. , 2012, Biochemical and biophysical research communications.

[8]  Min Wang,et al.  Luteolin induced G2 phase cell cycle arrest and apoptosis on non-small cell lung cancer cells. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.

[9]  W. Cheng,et al.  Radiosensitization effect of luteolin on human gastric cancer SGC-7901 cells. , 2009, Journal of Biological Regulators and Homeostatic Agents.